The price of Precigen Inc (NASDAQ:PGEN) shares last traded on Wall Street fell -3.57% to $1.08.
PGEN stock price is now 28.04% away from the 50-day moving average and -9.76% away from the 200-day moving average. The market capitalization of the company currently stands at $316.30M.
, while ‘Cantor Fitzgerald’ rates the stock as ‘Overweight’
In other news, Perez Jeffrey Thomas, SVP, IP Affairs bought 58,823 shares of the company’s stock on Aug 09 ’24. The stock was bought for $50,000 at an average price of $0.85. Upon completion of the transaction, the SVP, IP Affairs now directly owns 743,097 shares in the company, valued at $0.8 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 09 ’24, Director KIRK RANDAL J bought 23,529,411 shares of the business’s stock. A total of $19,999,999 was incurred on buying the stock at an average price of $0.85. This leaves the insider owning 64,547,214 shares of the company worth $69.71 million. A total of 49.60% of the company’s stock is owned by insiders.
During the past 12 months, Precigen Inc has had a low of $0.65 and a high of $1.93. As of last week, the company has a debt-to-equity ratio of 0.10, a current ratio of 1.63, and a quick ratio of 1.63. The fifty day moving average price for PGEN is $0.8404 and a two-hundred day moving average price translates $1.1986 for the stock.
The latest earnings results from Precigen Inc (NASDAQ: PGEN) was released for 2024-06-30. The net profit margin was -3521.68% and return on equity was -137.46% for PGEN. The company reported revenue of $0.95 million for the quarter, compared to $1.38 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -30.89 percent.
